AAAAAA

   
Results: 1-25 |
Results: 25
A MULTIPLE-DOSE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF A HUMANIZED ANIT-CD4 MONOCLONAL-ANTIBODY IN THE TREATMENT OF MODERATE TO SEVERE CHRONIC PSORIASIS-VULGARIS
Authors: GOTTLIEB AB KRUEGER J LEBWOHL M GISOLDI E GROSSMAN RM WACHOLTZ MC
Citation: Ab. Gottlieb et al., A MULTIPLE-DOSE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF A HUMANIZED ANIT-CD4 MONOCLONAL-ANTIBODY IN THE TREATMENT OF MODERATE TO SEVERE CHRONIC PSORIASIS-VULGARIS, Journal of investigative dermatology, 110(4), 1998, pp. 678-678
STUDIES OF THE EFFECTS OF TOPICAL VITAMIN-C, A COPPER-BINDING CREAM, AND MELATONIN CREAM AS COMPARED WITH TRETINOIN ON THE ULTRASTRUCTURE OF NORMAL SKIN
Authors: ABDULGHANI AA SHIRIN S MORALESTAPLA E SHERR A SOLODKINA G ROBERTSON M GOTTLIEB AB
Citation: Aa. Abdulghani et al., STUDIES OF THE EFFECTS OF TOPICAL VITAMIN-C, A COPPER-BINDING CREAM, AND MELATONIN CREAM AS COMPARED WITH TRETINOIN ON THE ULTRASTRUCTURE OF NORMAL SKIN, Journal of investigative dermatology, 110(4), 1998, pp. 686-686
IDENTIFICATION OF ABERRANTLY REGULATED GENES IN DISEASED SKIN USING THE CDNA DIFFERENTIAL DISPLAY TECHNIQUE
Authors: RIVAS MV JARVIS ED MORISAKI S CARBONARO H GOTTLIEB AB KRUEGER JG
Citation: Mv. Rivas et al., IDENTIFICATION OF ABERRANTLY REGULATED GENES IN DISEASED SKIN USING THE CDNA DIFFERENTIAL DISPLAY TECHNIQUE, Journal of investigative dermatology, 108(2), 1997, pp. 188-194
THE CHALLENGES OF TREATING MODERATE TO SEVERE PSORIASIS
Authors: GOTTLIEB AB
Citation: Ab. Gottlieb, THE CHALLENGES OF TREATING MODERATE TO SEVERE PSORIASIS, International journal of dermatology, 36, 1997, pp. 41-44
INTRAVENOUS CYCLOSPORINE THERAPY IN THE TREATMENT OF PYODERMA-GANGRENOSUM SECONDARY TO CROHNS-DISEASE
Authors: CARP JM ONUMA E DAS K GOTTLIEB AB
Citation: Jm. Carp et al., INTRAVENOUS CYCLOSPORINE THERAPY IN THE TREATMENT OF PYODERMA-GANGRENOSUM SECONDARY TO CROHNS-DISEASE, Cutis, 60(3), 1997, pp. 135-138
IMMUNOPATHOGENESIS OF PSORIASIS - THE ROAD FROM BENCH TO BEDSIDE IS A2-WAY STREET
Authors: GOTTLIEB AB
Citation: Ab. Gottlieb, IMMUNOPATHOGENESIS OF PSORIASIS - THE ROAD FROM BENCH TO BEDSIDE IS A2-WAY STREET, Archives of dermatology, 133(6), 1997, pp. 781-782
CELLULAR ACTIONS OF ETRETINATE IN PSORIASIS - ENHANCED EPIDERMAL DIFFERENTIATION AND REDUCED CELL-MEDIATED INFLAMMATION ARE UNEXPECTED OUTCOMES
Authors: GOTTLIEB SL HAYES E GILLEAUDEAU P CARDINALE I GOTTLIEB AB KRUEGER JG
Citation: Sl. Gottlieb et al., CELLULAR ACTIONS OF ETRETINATE IN PSORIASIS - ENHANCED EPIDERMAL DIFFERENTIATION AND REDUCED CELL-MEDIATED INFLAMMATION ARE UNEXPECTED OUTCOMES, Journal of cutaneous pathology, 23(5), 1996, pp. 404-418
MODULATION OF EPIDERMAL DIFFERENTIATION, TISSUE INFLAMMATION, AND T-LYMPHOCYTE INFILTRATION IN PSORIATIC PLAQUES BY TOPICAL CALCITRIOL
Authors: LU I GILLEAUDEAU P MCLANE JA HEFTLER N KAMBER M GOTTLIEB S KRUEGER JG GOTTLIEB AB
Citation: I. Lu et al., MODULATION OF EPIDERMAL DIFFERENTIATION, TISSUE INFLAMMATION, AND T-LYMPHOCYTE INFILTRATION IN PSORIATIC PLAQUES BY TOPICAL CALCITRIOL, Journal of cutaneous pathology, 23(5), 1996, pp. 419-430
IN-VIVO EXPRESSION OF THE INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) RECEPTOR IN CONGENITAL PIGMENTED NEVI
Authors: HODAK E GOTTLIEB AB COLEN S ANZILOTTI M KRUEGER JG
Citation: E. Hodak et al., IN-VIVO EXPRESSION OF THE INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) RECEPTOR IN CONGENITAL PIGMENTED NEVI, Journal of cutaneous pathology, 23(1), 1996, pp. 19-24
PHARMACOKINETICS AND PHARMACODYNAMICS OF AC137 (25,28,29-TRIPRO-AMYLIN, HUMAN) AFTER INTRAVENOUS BOLUS AND INFUSION DOSES IN PATIENTS WITH INSULIN-DEPENDENT DIABETES
Authors: COLBURN WA GOTTLIEB AB KODA J KOLTERMAN OG
Citation: Wa. Colburn et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF AC137 (25,28,29-TRIPRO-AMYLIN, HUMAN) AFTER INTRAVENOUS BOLUS AND INFUSION DOSES IN PATIENTS WITH INSULIN-DEPENDENT DIABETES, Journal of clinical pharmacology, 36(1), 1996, pp. 13-24
THE INSULIN-LIKE GROWTH-FACTOR-1 RECEPTOR IS EXPRESSED BY EPITHELIAL-CELLS WITH PROLIFERATIVE POTENTIAL IN HUMAN EPIDERMIS AND SKIN APPENDAGES - CORRELATION OF INCREASED EXPRESSION WITH EPIDERMAL HYPERPLASIA
Authors: HODAK E GOTTLIEB AB ANZILOTTI M KRUEGER JG
Citation: E. Hodak et al., THE INSULIN-LIKE GROWTH-FACTOR-1 RECEPTOR IS EXPRESSED BY EPITHELIAL-CELLS WITH PROLIFERATIVE POTENTIAL IN HUMAN EPIDERMIS AND SKIN APPENDAGES - CORRELATION OF INCREASED EXPRESSION WITH EPIDERMAL HYPERPLASIA, Journal of investigative dermatology, 106(3), 1996, pp. 564-570
RESPONSE OF PSORIASIS TO A LYMPHOCYTE-SELECTIVE TOXIN (DAB(389)IL-2) SUGGESTS A PRIMARY IMMUNE, BUT NOT KERATINOCYTE, PATHOGENIC BASIS
Authors: GOTTLIEB SL GILLEAUDEAU P JOHNSON R ESTES L WOODWORTH TG GOTTLIEB AB KRUEGER JG
Citation: Sl. Gottlieb et al., RESPONSE OF PSORIASIS TO A LYMPHOCYTE-SELECTIVE TOXIN (DAB(389)IL-2) SUGGESTS A PRIMARY IMMUNE, BUT NOT KERATINOCYTE, PATHOGENIC BASIS, Nature medicine, 1(5), 1995, pp. 442-447
SHORT-CONTACT ANTHRALIN TREATMENT AUGMENTS THERAPEUTIC EFFICACY OF CYCLOSPORINE IN PSORIASIS - A CLINICAL AND PATHOLOGICAL-STUDY
Authors: GOTTLIEB SL HEFTLER NS GILLEAUDEAU P JOHNSON R VALLAT VP WOLFE J GOTTLIEB AB KRUEGER JG
Citation: Sl. Gottlieb et al., SHORT-CONTACT ANTHRALIN TREATMENT AUGMENTS THERAPEUTIC EFFICACY OF CYCLOSPORINE IN PSORIASIS - A CLINICAL AND PATHOLOGICAL-STUDY, Journal of the American Academy of Dermatology, 33(4), 1995, pp. 637-645
ETRETINATE PROMOTES KERATINOCYTE TERMINAL DIFFERENTIATION AND REDUCEST-CELL INFILTRATION IN PSORIATIC EPIDERMIS
Authors: GOTTLIEB SL COATS E GILLEAUDEAU P GOTTLIEB AB KRUEGER JG
Citation: Sl. Gottlieb et al., ETRETINATE PROMOTES KERATINOCYTE TERMINAL DIFFERENTIATION AND REDUCEST-CELL INFILTRATION IN PSORIATIC EPIDERMIS, Journal of investigative dermatology, 104(4), 1995, pp. 645-645
USE OF THE MESSENGER-RNA DIFFERENTIAL DISPLAY TECHNIQUE TO IDENTIFY AND CLASSIFY ALTERED GENE-TRANSCRIPTION IN REGENERATIVE EPIDERMAL DIFFERENTIATION AND IN PSORIASIS
Authors: RIVAS MV JARVIS ED CARBONARO H GOTTLIEB AB KRUEGER JG
Citation: Mv. Rivas et al., USE OF THE MESSENGER-RNA DIFFERENTIAL DISPLAY TECHNIQUE TO IDENTIFY AND CLASSIFY ALTERED GENE-TRANSCRIPTION IN REGENERATIVE EPIDERMAL DIFFERENTIATION AND IN PSORIASIS, Journal of investigative dermatology, 104(4), 1995, pp. 675-675
SUCCESSFUL ULTRAVIOLET-B TREATMENT OF PSORIASIS IS ACCOMPANIED BY A REVERSAL OF KERATINOCYTE PATHOLOGY AND BY SELECTIVE DEPLETION OF INTRAEPIDERMAL T-CELLS
Authors: KRUEGER JG WOLFE JT NABEYA RT VALLAT VP GILLEAUDEAU P HEFTLER NS AUSTIN LM GOTTLIEB AB
Citation: Jg. Krueger et al., SUCCESSFUL ULTRAVIOLET-B TREATMENT OF PSORIASIS IS ACCOMPANIED BY A REVERSAL OF KERATINOCYTE PATHOLOGY AND BY SELECTIVE DEPLETION OF INTRAEPIDERMAL T-CELLS, The Journal of experimental medicine, 182(6), 1995, pp. 2057-2068
THE HUMAN AMYLIN ANALOG AC137 REDUCES MEAN 24-HOUR GLUCOSE IN TYPE-I DIABETES
Authors: THOMPSON RG GOTTLIEB AB PETERSON J
Citation: Rg. Thompson et al., THE HUMAN AMYLIN ANALOG AC137 REDUCES MEAN 24-HOUR GLUCOSE IN TYPE-I DIABETES, Diabetologia, 38, 1995, pp. 44-44
REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA IN PATIENTS WITH TYPE-II DIABETES BY THE HUMAN AMYLIN ANALOG-AC137
Authors: KOLTERMAN OG GOTTLIEB AB ORGAN KA THOMPSON RG
Citation: Og. Kolterman et al., REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA IN PATIENTS WITH TYPE-II DIABETES BY THE HUMAN AMYLIN ANALOG-AC137, Diabetologia, 38, 1995, pp. 193-193
THE HUMAN AMYLIN ANALOG (AC137) REDUCES GLUCOSE FOLLOWING SUSTACAL(R)IN PATIENTS WITH TYPE-II DIABETES
Authors: THOMPSON RG GOTTLIEB AB ORGAN K KOLTERMAN OG
Citation: Rg. Thompson et al., THE HUMAN AMYLIN ANALOG (AC137) REDUCES GLUCOSE FOLLOWING SUSTACAL(R)IN PATIENTS WITH TYPE-II DIABETES, Diabetes, 44, 1995, pp. 127-127
GM-CSF ACTIVATES REGENERATIVE EPIDERMAL GROWTH AND STIMULATES KERATINOCYTE PROLIFERATION IN HUMAN SKIN IN-VIVO
Authors: BRAUNSTEIN S KAPLAN G GOTTLIEB AB SCHWARTZ M WALSH G ABALOS RM FAJARDO TT GUIDO LS KRUEGER JG
Citation: S. Braunstein et al., GM-CSF ACTIVATES REGENERATIVE EPIDERMAL GROWTH AND STIMULATES KERATINOCYTE PROLIFERATION IN HUMAN SKIN IN-VIVO, Journal of investigative dermatology, 103(4), 1994, pp. 601-604
USE OF THE MESSENGER-RNA DIFFERENTIAL DISPLAY TECHNIQUE TO ISOLATE GENES ACTIVATED IN PSORIASIS
Authors: RIVAS MV JARVIS ED CARBONARO H GOTTLIEB AB KREUGER JG
Citation: Mv. Rivas et al., USE OF THE MESSENGER-RNA DIFFERENTIAL DISPLAY TECHNIQUE TO ISOLATE GENES ACTIVATED IN PSORIASIS, Journal of investigative dermatology, 102(4), 1994, pp. 530-530
PUVA BATH THERAPY STRONGLY SUPPRESSES IMMUNOLOGICAL AND EPIDERMAL ACTIVATION IN PSORIASIS - A POSSIBLE CELLULAR BASIS FOR REMITTIVE THERAPY
Authors: VALLAT VP GILLEAUDEAU P BATTAT L WOLFE J NABEYA R HEFTLER N HODAK E GOTTLIEB AB KRUEGER JG
Citation: Vp. Vallat et al., PUVA BATH THERAPY STRONGLY SUPPRESSES IMMUNOLOGICAL AND EPIDERMAL ACTIVATION IN PSORIASIS - A POSSIBLE CELLULAR BASIS FOR REMITTIVE THERAPY, The Journal of experimental medicine, 180(1), 1994, pp. 283-296
ADMINISTRATION OF TRIPRO-AMYLIN REDUCES POSTPRANDIAL HYPERGLYCEMIA INSUBJECTS WITH JUVENILE-ONSET DIABETES
Authors: KOLTERMAN OG GOTTLIEB AB MOYSES CJ
Citation: Og. Kolterman et al., ADMINISTRATION OF TRIPRO-AMYLIN REDUCES POSTPRANDIAL HYPERGLYCEMIA INSUBJECTS WITH JUVENILE-ONSET DIABETES, Diabetologia, 37, 1994, pp. 10000072-10000072
ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - REPLY
Authors: GILLEAUDEAU P VALLAT VP CARTER DM GOTTLIEB AB
Citation: P. Gilleaudeau et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - REPLY, Journal of the American Academy of Dermatology, 29(6), 1993, pp. 1062-1062
HUMAN KERATINOCYTE GROWTH-FACTOR EFFECTS IN A PORCINE MODEL OF EPIDERMAL WOUND-HEALING
Authors: STAIANOCOICO L KRUEGER JG RUBIN JS DLIMI S VALLAT VP VALENTINO L FAHEY T HAWES A KINGSTON G MADDEN MR MATHWICH M GOTTLIEB AB AARONSON SA
Citation: L. Staianocoico et al., HUMAN KERATINOCYTE GROWTH-FACTOR EFFECTS IN A PORCINE MODEL OF EPIDERMAL WOUND-HEALING, The Journal of experimental medicine, 178(3), 1993, pp. 865-878
Risultati: 1-25 |